Phathom Pharmaceuticals, Inc.PHATNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
60.95%
↑ 128% above average
Average (30q)
-220.95%
Historical baseline
Range
High:79.47%
Low:-6720.00%
Volatility
-3077.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 60.95% |
| Q2 2025 | 19.85% |
| Q1 2025 | -24.76% |
| Q4 2024 | 20.45% |
| Q3 2024 | 15.38% |
| Q2 2024 | -9.86% |
| Q1 2024 | -2.16% |
| Q4 2023 | -82.89% |
| Q3 2023 | 9.52% |
| Q2 2023 | 5.62% |
| Q1 2023 | 42.21% |
| Q4 2022 | 0.00% |
| Q3 2022 | -15.79% |
| Q2 2022 | -16.67% |
| Q1 2022 | -20.00% |
| Q4 2021 | 3.06% |
| Q3 2021 | 2.00% |
| Q2 2021 | -4.17% |
| Q1 2021 | 39.24% |
| Q4 2020 | -54.90% |
| Q3 2020 | -59.38% |
| Q2 2020 | -3.23% |
| Q1 2020 | 79.47% |
| Q4 2019 | -1.34% |
| Q3 2019 | 70.87% |
| Q2 2019 | -6720.00% |
| Q1 2019 | -165.96% |
| Q4 2018 | -66.86% |
| Q3 2018 | 29.88% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |